Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Second generation S1P pathway modulators: Research strategies and clinical developments.
Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Linkage of multiple sclerosis and guillain-barre syndrome: a population-based survey in isfahan, iran.
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies.
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
Central Veins in Brain Lesions Visualized With High-Field Magnetic Resonance Imaging: A Pathologically Specific Diagnostic Biomarker for Inflammatory Demyelination in the Brain.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Brain stem and cerebellar atrophy in chronic progressive neuro-Behçet's disease.
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
Meta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medication.
CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients.
Multiple sclerosis severity score in a cohort of Moroccan patients.
Natalizumab in the treatment of pediatric multiple sclerosis.
Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Acute lumbosacral transverse myelitis.
A Voxel-based Morphometry Study of Grey Matter Volume Changes in Neuromyelitis Optica Patients.
Leukoencephalopathy due to Oral Methotrexate.
Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Risk factors for idiopathic optic neuritis recurrence.
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
Association of sex hormones and glucose metabolism with the severity of multiple sclerosis.
Protein fibrillation and nanoparticle interactions: opportunities and challenges.
Pages
« first
‹ previous
…
304
305
306
307
308
309
310
311
312
…
next ›
last »